A new awareness-raising effort from Incyte is aimed at giving doctors an up-close look at the emotional and physical challenges their patients with hidradenitis suppurativa face. More: Incyte bares 'whole truth' of living with hidradenitis suppurativa in new HCP campaign
read moreOri Biotech has lassoed a significant milestone for its cell and gene therapy manufacturing platform, IRO, which now boasts a coveted Advanced Manufacturing Technology designation from the FDA. More: Ori's cell and gene platform wins key FDA advanced manufacturing designation
read moreAfter joining multiple other drugmakers on the U.S. investment bandwagon earlier this year, Gilead Sciences is providing further details on where it plans to channel its $32 billion pledge. More: Gilead breaks ground on Foster City manufacturing hub as B
read moreThe drug manufacturer lobby’s seven-figure campaign, set to run through the end of the year, portrays fictional nonprofit hospital leaders celebrating profits derived from the program’s discounts. More: PhRMA launches ad campaign urging Congress to address '340B medicine mark-ups' Source:
read moreThe move forms the next step in the company’s long-held plan to exit manufacturing operations in India, with its Bangalore site expected to cease operations over the 2025-2026 Indian fiscal year. More: AstraZeneca, exiting production digs in India, surrenders local
read more
Trial explores regenerative macrophage therapy for liver disease More: Resolution Therapeutics doses first patient in EMERALD study of RTX001 Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals